Table 2 Association of patient clustering by downregulated responsive genes with clinical parameters
From: Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism
Status | Group 1 (n= 117) | Group 2 (n= 141) | Fisher's exact P-value |
|---|---|---|---|
ER+, n | 88 | 131 | 0.00001128 |
PR+, n | 71 | 121 | 0.00000411 |
LN+, n | 49 | 35 | 0.00183468 |
Tumor grade 3, n | 50 | 5 | 0.0 |